Empery Asset Management, LP 13D/13G Filings for Kiora Pharmaceuticals, Inc. (KPRX)

Empery Asset Management, LP 13D and 13G filings for Kiora Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-24
10:33 am
Purchase
2021-12-31 13G Kiora Pharmaceuticals, Inc.
KPRX
Empery Asset Management, LP 1,484
4.050%
1,484increase
(New Position)
Filing